Teva Pharma Industries Ltd ADR (TEVA) stock price

Teva Pharma Industries Ltd ADR (TEVA) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE. Price $38.98 (-0.54%), Market cap $41.17B, P/E ratio 26.39, 52-week low–high $15.38 ~ $36.34.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as cont

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Teva Pharma Industries Ltd ADR are updated in real time on BlackAll Trade.

Teva Pharma Industries Ltd ADR financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Teva Pharma Industries Ltd ADR (TEVA) stock price?

Teva Pharma Industries Ltd ADR trades at $38.98 (-0.54%). Real-time quotes and charts are available on BlackAll Trade.

What is the Teva Pharma Industries Ltd ADR (TEVA) market cap?

Teva Pharma Industries Ltd ADR has a market cap of about $41.17B. Its P/E ratio is 26.39.

What does Teva Pharma Industries Ltd ADR (TEVA) do?

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internatio